Sagimet Biosciences Inc. Series A Common Stock (SGMT) Insider Trading
Total insider buys:
- $1,295,153.50
Total insider sells:
- $0.00
Most recent insider trade:
- March 26, 2024
Most active insider trader:
- David Happel
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 26, 2024 | CEO | 12,100 | $5.27 | Buy | $63,767.00 | |
| Nov. 16, 2023 | CEO | 590 | $2.35 | Buy | $1,386.50 | |
| July 18, 2023 | Director | 46,875 | $16.00 | Buy | $750,000.00 | |
| July 18, 2023 | Major Shareholder | 30,000 | $16.00 | Buy | $480,000.00 |
First«1 of 1»Last
Insiders are buying Sagimet Biosciences Inc. Series A Common Stock stock.
The insider traders at Sagimet Biosciences Inc. Series A Common Stock are: David Happel, Beth C Seidenberg, and Enterprise Associates 13 L New
The most active insider trader at Sagimet Biosciences Inc. Series A Common Stock is David Happel with 2 trades.
Beth C Seidenberg has bought the most Sagimet Biosciences Inc. Series A Common Stock stock with a total value of $1,500,000.00.
The most recent insider trade for Sagimet Biosciences Inc. Series A Common Stock was on March 26, 2024.
The single biggest insider buy for Sagimet Biosciences Inc. Series A Common Stock was from Beth C Seidenberg with a total value of $750,000.00 on July 18, 2023.